PRLB - NYSE

Greetings, and welcome to Proto Labs Fourth Quarter and Full Year 2025 Earnings Call. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. If anyone requires operator assistance during the conference, please press. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Ryan Johnsrud, Investor Relations. Thank you. Please go ahead. Thank you, Donna.

Good morning, everyone, and welcome to Proto Labs' fourth quarter and full year 2025 earnings conference call. I am joined today by Suresh Krishna, President and Chief Executive Officer, and Dan Schumacher, Chief Financial Officer. This morning, Proto Labs issued a press release announcing its financial results for the fourth quarter and full year ended December 31, 2025. The release is available on the company's website. In addition, a prepared slide presentation is available online at the web address provided in our press release. Our discussion today will include statements relating to future performance and expectations that are or may be considered forward-looking statements and subject to many risks and uncertainties that could cause actual results to differ materially from expectations. Please refer to our earnings press release and recent SEC filings, including our annual report on Form 10-K, for information on certain risks that could cause actual outcomes to differ materially and adversely from any forward-looking statements made today. The results and guidance we will discuss include non-GAAP financial measures consistent with our past practice. Please refer to our press release and the accompanying slide presentation at the Investor Relations section of our company website for a complete reconciliation of GAAP to non-GAAP results. With that, I will now turn the call over to Suresh Krishna. Suresh?

Thanks, Ryan. Good morning, everyone, and thank you for joining our fourth quarter and full year earnings call. I am pleased to share our strong financial performance in 2025 and outline our strategic priorities as we move into 2026. Eight months into this role, I've spent significant time with customers, engineers, operators, and investors. What's become clear is that Proto Labs has exceptional assets and market relevance, but in recent years, we haven't fully translated that into consistent execution. The results this quarter are an early indication of what's possible when we align execution around the right priorities. We finished the year with clear momentum delivering double-digit year-over-year growth and another record revenue quarter. In constant currencies, fourth quarter revenue increased 11% and full year revenue grew 6%, representing Proto Labs' strongest quarterly and annual organic growth rate since 2018. Revenues per customer grew 13% in 2025, demonstrating major success on a key priority. In addition, we delivered year-over-year growth in earnings and generated another strong cash flow, reinforcing the strength of our business model. This was fueled by exceptional demand for CNC machining and sheet metal, which both delivered double-digit growth in 2025. In fact, US CNC revenue grew 25% in 2025. I'd like to thank Mark Dursa, our Senior Director of CNC Operations, and his team for their exceptional execution in delivering on robust CNC demand. Innovation-driven industries like drones, space exploration, satellites, and robotics continue to rely on Proto Labs as a critical partner. We also see strong momentum in data centers, another high-growth market where Proto Labs enables faster execution for customers like Amphenol and CommScope, leaders in data center infrastructure solutions. These are well-funded and long-cycle markets where our digital manufacturing model creates a durable, competitive advantage and has us well-positioned for 2026. Our financial results reflect Proto Labs' progress in improving the customer experience, strengthening customer relationships, and executing with speed, focus, and discipline. As a result of our strong finish in 2025, we've entered 2026 from a position of strength with clear momentum and growing confidence in the opportunities ahead. Now shifting to our long-term strategy, we have clarified our strategy to serve customers across the entire life cycle of a part, from prototype to production. This strategic direction is not new. However, what is new is the rigor, focus, and execution plan behind it. This approach reinforces our position as the world's fastest and most reliable provider of prototype parts, while deliberately building the capabilities required to be a trusted production supplier. Importantly, this strategy builds from our core strengths rather than shifting away from them. Excellence in prototyping and leadership in digital manufacturing are the foundations of our advantage, and they are the capabilities that enable us to expand credibly into production. Execution of this strategy is anchored by four strategic pillars. Number one, elevate customer experience, Number two, accelerate innovation, Number three, expand production, and Number four, drive operational efficiency.

First,

we are elevating the customer experience by removing friction, making it easier for customers to do business with Proto Labs and more efficient for our teams to serve them. Our strategy centers on deepening customer relationships and driving higher conversion, retention, and revenue per customer, ultimately improving unit economics and operating leverage. One tangible example is improvements to our e-commerce customer experience. Today, multiple factory and network storefronts create unnecessary friction. A more unified experience will simplify the customer journey and allow our teams to support customers more consistently and efficiently. With our second strategic pillar, accelerate innovation, we intend to return Proto Labs to its legacy of rapid, differentiated innovation, expanding offerings across our core manufacturing services to drive outsized growth. As one of the earliest and largest digital manufacturers, Proto Labs has unique assets that differentiate us, including over 60 patents and more than 60 trade secrets, a robust and growing CAD dataset, and deep experience applying automation and AI at scale. We are now translating these assets into a faster, more consistent cadence of customer-facing product and service launches through 2026 and beyond. Innovation for us means expanding manufacturing capabilities, improving speed and precision, enhancing coating and manufacturability feedback, and deploying smarter pricing and sourcing algorithms, always grounded in customer needs and clear return on investment. Next, expand production. While we currently offer production, our capabilities and customer engagement have historically been weighted towards prototyping. We are now strengthening the capabilities and certifications needed for true production work, opening access to a much larger market opportunity as we scale. For Proto Labs, expanding production requires a more deliberate customer-led approach, prioritizing the right customers, applications, and capabilities to unlock this opportunity. In January, we achieved ISO 13485 certification for our US factory injection molding operation, a critical requirement for medical device production programs. We already support prototyping work for all major medical device companies, and this certification opens a substantial opportunity to expand into production over the coming years. Moving forward, we will continue to add certifications and other capabilities required for production expansion. Our fourth strategic pillar, drive operational efficiency, enables profitable growth through improved productivity and cost discipline. This pillar is critical. It funds investments across the first three while acting as a force multiplier for profitability. This includes expanding factory and network gross margins, leveraging SG&A more effectively, simplifying how we operate, utilizing AI, and reallocating resources towards the highest priority initiatives. Each of our four strategic pillars reinforces the others, and collectively, they drive a more customer-centric, innovative, efficient, and scalable Proto Labs. While this strategy defines our organic priorities, selective inorganic opportunities can further advance our progress. We will continue to evaluate acquisitions that strengthen our capabilities and align closely with our strategic framework. We will remain disciplined and focused on opportunities that create durable, long-term shareholder value. With our long-term strategy established, let's shift to 2026. We expect 2026 will be a year of transformation and growth focused on execution. We are making foundational organizational, operational, and capability-building changes that position Proto Labs for faster growth and improved profitability. The first change is getting the right talent in place and properly structured. Mark Kermesch, our Chief Technology and AI Officer, is leading a reorganization of our technology group into a domain-focused organization structure, which better aligns how we build technology with how Proto Labs creates value for customers. Our product management teams are now part of Mark's technology organization, helping remove silos and accelerate innovation. The second change is focused on continuous improvement and quality. We are expanding our business operating system, which we call Proto Excellence, beyond our factory manufacturing operations and deploying it across the organization to drive productivity. We are also adding talent with significant manufacturing expertise to our quality team as we continue to build production capabilities. The third change for 2026 is the establishment of a global capability center or GCC in India. Proto Labs India will be a strategic extension of our global operating model designed to scale innovation, strengthen delivery, and deepen our global engineering and digital capabilities. Proto Labs India will serve as an integrated hub that complements our US and European teams, tapping into India's deep technical talent. Ashish Sharma has been appointed to lead this effort. Ashish has built and scaled GCCs for several large industrial companies, and we are excited to have him on board. Fourth, we are making important changes in Europe in 2026. Europe plays a critical role in Proto Labs' future, but revenues have declined over the past two years amid macro uncertainty as well as internal complexity that created friction for customers and employees. As a result, we are taking deliberate action to reset the business. We are implementing new go-to-market strategies and a renewed customer focus to reaccelerate revenue growth, aligning our cost structure with current revenue levels and improving productivity. We believe our addressable market size in Europe is similar to the US. Europe is not a growth drag structurally; it is an execution opportunity. Our strategic reset actions in 2026 are designed to stabilize margins and reset the cost base, positioning the region for growth and profitability. While 2026 is a year of transformation, it is also a year of acceleration. Here are a few initiatives that we expect will drive growth in 2026. On elevating the customer experience in Q1, we plan to launch ProDesk, a customer-facing experience designed to improve

customers'

engagement with Proto Labs across ordering, collaboration, and service. ProDesk is an important first step in improving the e-commerce experience through better user experience and functionality, while we continue to work towards a more fully unified platform over time. This initial launch is focused on removing friction today and setting the foundation for broader e-commerce simplification in the future. On accelerating innovation, we already released a few capability expansions late in 2025, including advanced CNC machining and expanded metal 3D printing. The pace of releases will continue in 2026, including improvements to our quoting experience, manufacturability software, expansions of our factory capabilities, additional secondary services, and more. As for expanding production, we will focus our efforts in 2026 on our largest and most strategic customers in aerospace and defense and medical, applying what we learn and scaling best practices across our customer base over time. We currently have two leading medical device customers in the pilot program, leveraging our new injection molding certifications and capabilities, including traceability, process validation, and automated inspection to support high precision production volumes. As you can see, we are making step changes in 2026 to achieve our four long-term strategic pillars. As a result of strong momentum exiting 2025 and the progress on key growth initiatives, we expect growth in 2026 to accelerate relative to 2025.

Importantly,

while 2026 reflects a year of transformation and measured acceleration, the structural changes we are making are designed to position Proto Labs for a return to sustained double-digit revenue growth. Our path to double-digit growth is driven by three levers. First, improving conversion and retention through an improved customer experience and accelerated innovation. Second, growing revenue per customer in part by expanding in production. And third, continuing to accelerate penetration in high-growth verticals like aerospace, defense, medical, robotics, and data centers. Taken together, our long-term strategy and transformational work underway in 2026 positions Proto Labs for sustained revenue growth and operating leverage over the long term, reinforcing our position as a leader in cash flow generation in our industry. We believe our strategic framework will translate into measurable financial progress over the next several years, beginning in 2026. As outlined above, Proto Labs has a credible path to a billion dollars in annual revenue over time while delivering meaningful operating margin expansion. I'm proud of what the team accomplished in 2025 and encouraged by the momentum we enter into 2026 and confident in our ability to execute with speed, discipline, and innovation as we deliver long-term value to our customers and shareholders. With that, I'll turn it over to Dan to walk through the financials. Dan?

Thanks, Suresh. And good morning. I'll start with a brief overview of our fourth quarter and full year results, followed by our outlook for 2026. Fourth quarter revenue was a company record of $136.5 million, up 11% year over year in constant currencies. This is also the first time since 2017 that we grew revenue sequentially in the fourth quarter. Fourth quarter revenue in the US grew 15.9% year over year, while Europe declined 8.1% in constant currencies. CNC revenue in the US grew 35% in the fourth quarter. Revenue fulfilled to Proto Labs network was $30.5 million, up 11.2% in constant currencies. Non-GAAP gross margin was 44.8%, up 140 basis points year over year as volume growth in the US factories generated higher gross margins. Fourth quarter non-GAAP operating expenses were $48.7 million, up $5.2 million compared to the prior year, driven by higher incentive compensation, commissions, and medical expenses. On a percent of revenue basis, fourth quarter operating expenses were down 10 basis points year over year. Non-GAAP earnings per share were $0.44, above our guidance range and up 6¢ year over year due to increased volume and factory gross margin improvements, partially offset by a higher tax rate. Now on to our full year 2025 financial highlights. Revenue was a record $533.1 million, up 5.7% in constant currencies. Factory revenue grew 3.7% and Proto Labs network revenue grew 13.8%. 2025 revenue in the US grew 9.1% year over year, while Europe revenue declined 7% in constant currencies. As Suresh discussed, we have focused efforts planned for 2026 to reset our European operation, generating efficiencies and returning the region to growth. In 2025, CNC machining revenue grew 16.7% year over year in constant currencies. Strong demand in the US for CNC parts in drones, satellites, and rockets drove this outstanding performance. In the US, CNC grew 25% year over year. Injection molding revenue declined 1.9%. The service was negatively impacted by weakness in medical device and lower prototyping demand. 3D printing declined 4.7% year over year due to weak prototype demand for 3D printed plastic parts and older technologies. However, we are seeing strength in metal 3D printing. DMLS revenue in the US grew double digits. Sheet metal grew 12% year over year. This service also benefited from strong demand in US aerospace and defense. Full year 2025 non-GAAP gross margin was 45.1% compared to 45.2% in 2024. Our gross margin is unmatched in digital manufacturing, a testament to the strength of our combined factory and network fulfillment model. Factory non-GAAP gross margin was 49%, up 70 basis points year over year. I'd like to commend our factory operations and continuous improvement teams for their productivity improvements in 2025. Network non-GAAP gross margin was 31%, down 190 basis points year over year largely due to inefficiencies related to tariffs. 2025 non-GAAP operating expenses were $193.3 million or 36.3% of revenue, up slightly from 36% of revenue in 2024. As we said throughout 2025, the majority of the SG&A increase was in variable expenses tied to revenue growth, including incentive compensation and commissions. However, there is significant opportunity for leverage on our operating costs as we scale. Suresh already outlined a number of transformational initiatives in 2026 meant to drive efficiencies and productivity. We expect efforts within our operational efficiency pillar to generate operating leverage in the long term. Non-GAAP earnings per share were $1.66, up 3¢ year over year. We generated $74.5 million in cash from operations in 2025, as Proto Labs continues to lead the digital manufacturing industry in cash generation. We returned $43 million to shareholders in the form of repurchases. On December 31, 2025, cash and investments on our balance sheet were $142.4 million and zero debt. Turning to our forward outlook. We have momentum in the business, and we are actively laying the foundation to invest in our strategic pillars and grow the business to $1 billion in revenue.

Our focus on long-term margin expansion

will be driven by revenue growth, factory utilization and productivity, network margin refinement, and SG&A leverage. As these drivers scale, we believe Proto Labs has a path to expand operating margins while continuing to lead the industry in cash generation. As Suresh mentioned, 2026 is a year of transformation and acceleration for Proto Labs. With that said, we anticipate full year 2026 GAAP revenue growth of 6 to 8%. As is our standard practice, we will provide both revenue and earnings guidance for 2026 outlined on Slide 19. We expect revenue between $130 million and $138 million. At the midpoint, this implies 6% revenue growth year over year. We expect foreign currency to have a $2.1 million favorable impact on revenue compared to 2025. Our earnings guidance incorporates the following assumptions for 2026. Non-GAAP add-backs will include stock-based compensation expense of approximately $3.6 million, amortization expense of $900,000, and transformation and restructuring costs of $700,000. A non-GAAP effective tax rate between 24-25%. In summary, we expect first quarter 2026 non-GAAP earnings per share between $0.36 and $0.44. That concludes our prepared remarks. Please open the line for questions.

Thank you. The floor is now open for questions.

Question queue.

You may press star 2 if you would like to remove your question from the queue. Pressing the star keys. Again, that's star 1 to register a question at this time. Our first question today is coming from Greg Palm of Craig Hallum. Please go ahead.

I wanted to maybe start off with a little bit more color on Q4. And by the way, congrats on a great finish to the year and a really improved year overall. But as you kind of mentioned, you know, first time in a long time where revenue actually grew sequentially from Q3 to Q4. And I guess I'll sort of ask the same question. I can't recall you ever sequentially declining from Q4 to Q1, but obviously, that's what the midpoint implies. So how much of that is conservatism? What exactly did you see in Q4? Was there some pull forward of revenues? And maybe just a little bit more color on what you've seen quarter to date.

Yeah. Thanks, Greg, and thanks for the congratulations. You know, you've followed us for some time. I've talked about this in the past. As you go into the fourth quarter, it ends up being quite unpredictable in terms of when customers will have projects. And what we saw is like, through November and December, continued, you know, good order volumes driven by, you know, our engagement with customers in those key industries. And so that resulted in the results that you see. As we started in January, it was a more normalized start to the year, it's softer as people are coming back from the holidays. And we've seen order rates improve from that point. So it hasn't been since 2017 that we've seen that where in the fourth quarter, people continue to order right to the end of the year. But we do see some normalization now starting in January.

Okay. That's fair enough. And then, you know, just in terms of end markets applications, I think you've talked about a few of them that you've been sort of seeing, you know, a lot of growth in recent history. But can you just maybe go in a little bit more detail, you know, whether, you know, A&D so that, you know, the drones and satellites, space, I also think you mentioned data centers, and you haven't talked about a lot in the past. But, you know, are you, you know, presumably, some of these end markets are accelerating, but just give us a little bit more color exactly what you're seeing.

Yeah. Thanks, Greg. We are absolutely seeing innovation-led growth in these markets. And as you know, we are the default go-to place for prototyping for innovation. We are absolutely well-positioned to leverage all of these growth markets that are well-funded, long-cycle innovations starting now. And we serve almost all of these industries. So we feel pretty good about where we are positioned to serve the innovation-led growth in the US right now.

Okay. And, Phil, lastly, appreciate some of the commentary on the strategic pillars. I'm curious how much or what can sort of be done near term versus midterm versus long term? And, I mean, do you think you're starting to see some of the results from some of these strategic initiatives already, or is this more of a sort of to come kind of thing?

Yeah. Greg, we are just starting this now. And we will see acceleration in the outer years. This is a year of transformation. We are putting things in place. And we are getting organized.

Okay. Keep it up. Best of luck. Thanks.

Thanks, Greg.

Thank you. Our next question is coming from Troy Jensen of Cantor Fitzgerald. Please go ahead.

Hey, gentlemen. Congrats on the great results.

Thanks, Troy. Maybe just a couple of questions.

Hey. Just a couple questions for me. Can you talk about just unique developers? It was down here, lowest we've seen in a bit? Is this a conscious decision to shed less profitable, or you just touch on the UDPs, please.

Yeah. Troy, you know, we are absolutely focused on increasing revenue per contact, and we saw acceleration in Q4 with revenue per contact up almost 23%. Having said that, we are also focused on driving more contacts, so we are aware that we have to grow both. But our focus has been to get more share of wallet from our existing customers, and that is borne by the facts of how Q4 performed. In fact, all of 2025 performed where we were up 13% year over year on revenue per contact.

Alright. Alright. Fair. So just different question here. Can you talk there's been chatter or just I know the administration's really kind of in pushing US supply chains for defense. And I've just heard chatter that they're out, you know, even kind of talking to the machine shop builders of the world. But anything that you guys can talk about here that's kind of reshoring or this US-based supply for defense? Is this something that you've had discussions with? Or talk to administration about?

And as you can see from our results, we have good exposure to aerospace and defense. Good exposure to all the growth areas within aerospace and defense that includes drones, satellites, rockets, robotics, and you're seeing good growth from all of those end markets.

Okay. But not specifically. Just defense really pushing US to reshore in the supply chains? It's more broad-based.

Yeah. I think, you know, I don't know how much specifics we can give you, but we have good exposure to all of these companies, and we are a preferred supplier to them when it comes to driving innovation.

Okay. Alright, guys. Keep up the good work.

Thanks, Troy.

Thank you. Our next question is coming from Brian Drab of William Blair. Please go ahead.

Since Troy is trying to get you to talk about all your defense work, I thought maybe I'd ask you to reveal all 63 secrets that you mentioned on the call. Can we talk through those?

They're secret for a reason, Brian.

I hadn't heard that stat before. 63 Secrets. I thought that was interesting. The injection molding business has been pretty steady here the last couple quarters, but, you know, this is obviously, you know, still one of the keys to the growth going forward is to reaccelerate growth in injection molding. I know that you've done some work around automation and you're working with enterprise customers, different verticals. But, like, what as you think about that 6 to 8% growth, which would be outstanding for 2026 for the overall company, what kind of visibility do you have to the injection molding business contributing to that type of growth? And I'm wondering if you just if you have some better visibility related to production programs with some customers or, you know, any color around that visibility would be great.

Yeah. Brian, thanks. Yeah. We have acknowledged in the past that prototyping in injection molding is down, and it remains down. Hence, our pivot towards production in injection molding in particular while we are going after production in all our service lines. Getting the ISO 13485 certification for the medical industry, which allows us to do traceability, process validation, and inspection, helps us pivot to more production in injection molding. We are in pilot with two medical device manufacturers right now for high precision, higher volume production parts for injection molding. And as that scales, we will be able to bring in more customers into that fold and thereby expand our injection molding revenues year over year.

Do you think that it's possible that injection molding grows at a comparable rate to CNC machining in 2026?

I don't think giving guidance as it relates to service at this point.

Fair. Okay. And then you launched these advanced CNC capabilities in October. And I'm just wondering is that still very early in the ramp, or did that affect, do you think, some of the CNC order activity in the fourth quarter?

Yeah. It's while it's early, it's performing well for us. We are only a few months in, but we are seeing significant excitement and customers wanting to use that service. It's something they've been asking us for a long time. When I talk about friction, it's these kinds of things where customers want something from us, and we are not responding. And we are able to do that now. And we are seeing a good lift for these services.

Okay. And then my last question for now is just on India. Should I be thinking about that as an opportunity to expand the network side of your business, which, you know, serving customers globally, or I think you mentioned I may have just missed it. Or is it more focused on, you know, customers with serving customers within India and the surrounding region?

Yeah. So we have been in India for some time with manufacturing partners that support our network business. By putting in a center in India, we are looking to expand how we can leverage India's technical talent to help us advance our innovation agenda, our AI agenda, and accelerate that with speed. So we are expanding India for supporting our global business.

Is it so is it am I what type of people are in this facility then? Is it software engineers or CNC machinists or what you know, can you just elaborate on that a little bit?

We'll share more as we build it out. We just started this in the beginning of the year. And as I said, we already had a presence with supplier quality engineers, supplier development engineers working with our manufacturing partners and making them capable to supply global customers in Europe and the US. And by putting in a head has helped build global capability centers, we can add more capability in our India office to support our entire business.

Okay. Perfect.

Thank you.

Thank you. Our next question is coming from Jim Ricchiuti of Needham and Company. Please go ahead.

Hi, good morning. I'm wondering, is this decision to share full year growth targets with us today, is that a function of what you're seeing in terms of opportunity? I'm not gonna call it predictable demand. I don't think that's something necessarily that characterizes your business. But I'm wondering, are you seeing this opportunity a better view of this opportunity in several of the key markets you've identified? Or is it just is this accelerating growth due to, you know, just greater confidence in the changes you're making and the potential for that to provide more immediate benefit? I'm not sure if that question is confusing. I'm just trying to get a sense because normally, you guys have not talked about full year revenue growth.

So, Jim, we just had a quarter in which we had 11% growth year over year. And Suresh just laid out some transformational change that we're going through. So it's a year of, you know, quite a bit of change for us. I don't have better visibility to what the full year is, but I thought it would be helpful to share with you and the investors where we're thinking about for the full year in terms of growth.

And that's very helpful. And I think appreciated. The other question I had is, given all the changes you're making, what are some of the puts and takes on the investments required? Do you anticipate additional investments as you go through the year to potentially, you know, lay those foundation for stronger growth, or is this also gonna be a reallocation of resources?

It's gonna be a, you know, one, it's a reallocation of resources. We are driving initiatives. You can see some of the we had a transformational charge in the fourth quarter. We've got one in the first quarter. So we are looking at eliminating costs in certain areas, but reinvesting them into others. So, you know, from a full year perspective, I would not expect us to be expanding margin. What we're gonna be doing is we're gonna be looking to lower cost, but at the same time, reinvest that cost to drive some of the transformational change that Suresh talked about and start really moving growth.

Got it. And just one quick follow-up. I may have missed it. Could you provide the network gross margin in the quarter? I think they were lower for the year, but I wasn't quite sure. You may have mentioned that I missed it.

Network margin in the quarter was 30.3%.

Thank you. And I'll add my congratulations real nice finish to the year.

Thank you, Jim. Thank you.